,i #aaeth ,,congress #b;d ,session ,h4 ,r4 #gjgi ,,in ,,the ,,house ,,of ,,representatives ,october #ai1 #bjah,ms4 ,kuster of ,new ,hampshire 7for herself1 ,mrs4 ,walorski1 ,ms4 ,jayapal1 ,ms4 ,bass1 ,mr4 ,cicilline1 ,ms4 ,esty of ,connecticut1 ,mr4 ,turner1 and ,mr4 ,langevin7 introduced the following bill2 which was referred to the ,committee on the ,judiciary ,a ,,bill ,to authorize the ,attorney ,general to make grants to1 and enter into cooperative agreements with1 ,states and units of local government to develop1 implement1 or expand a program to provide medication-assisted treatment1 from arrest to release1 to individuals incarcerated in the jurisdiction who are addicted to opioids1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,corrections ,public ,health and ,community ,re-entry ,act of #bjah4 #b4 ,medication ,assisted ,treatment ,community ,re-entry ,program 7a7 ,authorization ,the ,attorney ,general1 acting through the ,director of the ,national ,institute of ,corrections1 is authorized to make grants to1 and enter into cooperative agreements with1 ,states and units of local government to develop1 implement1 or expand a program to provide medication-assisted treatment to individuals incarcerated in the jurisdiction who are addicted to opioids4 7b7 ,purposes ,the purposes of the program under this section are to-- 7#a7 develop medication-assisted treatment programs1 in consultation with nonprofit organizations qualified to provide technical support for such programs2 7#b7 reduce the risk of overdose to individuals following release from incarceration2 and 7#c7 reduce the rate of recidivism4 7c7 ,program requirements ,a program described in subsection 7a7 which is funded by a grant or a cooperative agreement under this section shall include the following3 7#a7 ,a sufficient number of providers who can prescribe 7or otherwise dispense7 and discuss with patients the risks of1 benefits of1 and differences between-- 7,a7 not less than #a opioid antagonist medication approved by the ,food and ,drug ,administration to treat addiction involving opioids2 and 7,b7 not less than #a opioid agonist 7or partial agonist7 medication approved by the ,food and ,drug ,administration to treat addiction involving opioids4 7#b7 ,a certified recovery coach to work with newly released individuals recovering from addiction to opioids1 in order to support the individual's sustained recovery4 7d7 ,application ,a jurisdiction seeking a grant or cooperative agreement under this section shall submit an application to the ,attorney ,general at such time1 in such manner1 and containing such information as the ,attorney ,general may reasonably require1 including-- 7#a7 a description of the objectives of the program and activities to be funded by the grant or cooperative agreement and how the grant or agreement will be used to achieve these objectives1 including specific activities and services to be conducted2 7#b7 a plan for measuring progress in achieving the objectives described in paragraph 7#a71 including a strategy to collect data that can be used to measure such progress2 7#c7 assurance that the prison or jail at which the program will be operated has1 or has access to1 a sufficient number of clinicians licensed to administer medication-assisted treatment to program participants1 which may include clinicians who are available using telemedicine2 7#d7 a plan for ensuring secure storage of medications and protocols for diversion prevention2 7#e7 a description of the program's outreach and education component1 in order to encourage maximum participation in the program2 7#f7 assurance that the program will provide psychosocial counseling services to compliment medication-assisted treatment2 and 7#g7 a plan for ensuring that program participants have continuity of care1 both with respect to medication-assisted treatment and psychosocial counseling services1 through community service providers after release from incarceration1 including providing assistance to eligible participants in registering for ,medicaid4 7e7 ,duration ,a grant awarded or cooperative agreement entered into under this section shall be for a period not to exceed #d years1 except that the ,attorney ,general may extend the term of such a grant or agreement based on outcome data or extenuating circumstances4 7f7 ,collaboration with corrections organization ,the ,attorney ,general shall establish a working relationship with a knowledgeable corrections organization with expertise in security1 medical health1 mental health1 and addiction care1 to oversee and support implementation of the program under this section1 including the use of evidence-based clinical practices4 7g7 ,report 7#a7 ,in general ,a jurisdiction that receives a grant or enters into a cooperative agreement under this section shall submit an annual report to the ,attorney ,general which includes information about the program funded by the grant or cooperative agreement1 including goals1 interventions1 outcomes 7including recidivism rates71 and expenditures4 7#b7 ,publication 7,a7 ,by recipient ,a jurisdiction that submits a report under paragraph 7#a7 shall make the report publicly available on the website of the appropriate department of corrections1 prison1 or jail4 7,b7 ,by ,attorney ,general ,the ,attorney ,general shall make each report received under paragraph 7#a7 publicly available on the website of the ,national ,institute of ,corrections4 7#c7 ,submission to ,congress ,on an annual basis1 the ,attorney ,general shall submit to ,congress a summary and compilation of the reports the ,attorney ,general received under paragraph 7#a7 for that year4 7h7 ,application review panel 7#a7 ,in general ,not later than #fj days after the date of the enactment of this ,act1 the ,attorney ,general shall establish a ,medication-,assisted ,treatment ,community ,re-entry ,application ,review ,panel1 which shall include-- 7,a7 employees of the ,department of ,justice2 7,b7 employees of the ,substance ,abuse and ,mental ,health ,service ,administration2 and 7,c7 other stakeholders with expert knowledge of the opioid epidemic1 drug treatment1 and community addiction services1 which may include law enforcement and public health entities4 7#b7 ,duties ,the review panel established under paragraph 7#a7 shall review and evaluate applications for grants and cooperative agreements under this section1 and make recommendations for the awarding of such grants and agreements to the ,attorney ,general4 7i7 ,publication of criteria in ,federal ,register ,not later than #ij days after the date of the enactment of this ,act1 and in consultation with the review panel established under subsection 7g71 the ,attorney ,general shall publish in the ,federal ,register the application process and criteria for grants and cooperative agreements under this section4 7j7 ,authorization of appropriations ,there is authorized to be appropriated #ej1jjj1jjj to carry out this section for each of fiscal years #bjai through #bjbb4 7k7 ,definitions ,in this section3 7#a7 ,the term medication-assisted treatment means the use of drugs or combinations of drugs that have1 under the ,federal ,food1 ,drug1 and ,cosmetic ,act or section #cea of the ,public ,health ,service ,act1 been approved for use in maintenance or detoxification treatment1 in combination with counseling and behavioral therapies1 to provide a comprehensive approach to the treatment of substance use disorders4 7#b7 ,the term psychosocial means the interrelation of social factors and individual thought and behavior4